Home Journals Progress in Chemistry
Progress in Chemistry

Abbreviation (ISO4): Prog Chem      Editor in chief: Jincai ZHAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
Review

Home Diagnosis of Myocardial Infarction: Aptamer-Based cTnI Sensing Technology

  • Zhiyuan Xu 1, 2 ,
  • Guowei Gao 1, 2 ,
  • Yansheng Li , 1, 2, * ,
  • Qingwei Liao 1, 2 ,
  • Jingfang Hu 1, 2 ,
  • Xueji Zhang 3
Expand
  • 1 Key Laboratory of Sensors, Beijing Information Science and Technology University,Beijing 100101, China
  • 2 Key Laboratory of Modern Measurement and Control Technology of Ministry of Education, Beijing Information Science and Technology University,Beijing 100192, China
  • 3 School of Biomedical Engineering, Shenzhen University,Shenzhen 518060, China
*Corresponding author e-mail:

Received date: 2022-12-28

  Revised date: 2023-06-14

  Online published: 2023-07-18

Supported by

National Natural Science Foundation of China(62101053)

R&D Program of Beijing Municipal Education Commission(KM202211232004)

Fundamental Research Funds for the Central Public Welfare Research Institutes(RXRC2022001)

Project of Construction and Support for high-level Innovative Teams of Beijing Municipal Institutions(BPHR20220124)

Abstract

Cardiac troponin I (cTnI) is a biomarker closely associated with acute myocardial infarction (AMI) and is considered as the "gold standard" for the diagnosis of AMI. A variety of cTnI detection techniques have been developed, including antibody-based and aptamer-based detection methodology. Aptamers are short DNA or RNA sequences that can specifically bind to the target, and have been used in the development of cTnI detection platforms due to their advantages of good stability, easy synthesis and low cost. In this paper, cTnI detection methods are divided into optical detection and electrochemical detection according to the signal transduction mode. This review introduces the current research progress of aptamer-based cTnI sensing technology, describes the detection principle, performance, advantages and disadvantages of various methods, summarizes cTnI sensing technology and prospects its development in home testing, hoping to provide reference for the development of more sensitive and portable cTnI sensors.

Contents

1 Introduction

2 Optical detection

2.1 Fluorescence detection method

2.2 Surface-enhanced Raman scattering

2.3 Electrochemical luminescence method

3 Electrochemical detection

3.1 Electrochemical impedance spectrum

3.2 Differential pulse voltammetry

3.3 Square wave voltammetry

4 Conclusion and outlook

Cite this article

Zhiyuan Xu , Guowei Gao , Yansheng Li , Qingwei Liao , Jingfang Hu , Xueji Zhang . Home Diagnosis of Myocardial Infarction: Aptamer-Based cTnI Sensing Technology[J]. Progress in Chemistry, 2023 , 35(8) : 1266 -1274 . DOI: 10.7536/PC221213

1 Introduction

Cardiovascular disease (CVD) is one of the diseases with the highest mortality rate in the world. According to the World Health Organization (WHO), the number of people dying from CVD will reach 23.3 million annually by 2030, of which acute myocardial infarction (AMI) accounts for about 85%[1~3]. Myocardial infarction refers to myocardial injury or necrosis caused by insufficient oxygen supply. Myocardial injury releases cardiac troponin (cTn) into the blood, resulting in an increase in the concentration of cTn in the blood[4]. Cardiac troponin complex is composed of three subunits: troponin C (TnC), cardiac troponin I (cTnI) and cardiac troponin T (cTnT), but only cTnI and cTnT are biomarkers with high correlation with myocardial injury, of which cTnI is identified as the "gold standard" for AMI diagnosis[5][6]. The normal cTnI level in human serum is less than 0.4 ng/mL, and if it exceeds this value, it indicates that the risk of AMI will increase. Within 3 to 4 hours after myocardial injury, the concentration of cTnI in blood will gradually increase[7]. During the COVID-19 epidemic, people's travel is blocked and public medical resources are seriously scarce. In order to reduce the risk of virus infection caused by the gathering of people, it is of great significance to realize the home detection of AMI[8,9]. Through the development of a rapid and sensitive cTnI detection platform, the concentration of cTnI in blood can be detected immediately and effectively, and the occurrence of AMI can be diagnosed, so as to intervene in the treatment of AMI in advance, reduce the delay of treatment time, and reduce the mortality of AMI[10].
At present, for the rapid diagnosis of AMI, researchers have designed and developed a variety of cTnI detection methods, including enzyme-linked immunosorbent assay (ELISA), surface plasmon resonance (SPR) and electrochemical immunoassay, among which ELISA is the most commonly used method for clinical detection of cTnI, with the advantages of good specificity and high sensitivity[11][12][13][14]. The existing method can realize the sensitive detection of cTnI, however, the detection method based on the principle of immune reaction uses antibody molecules as a sensitive source to recognize cTnI, and the antibody has the disadvantages of high production cost, long production time and easy irreversible denaturation at room temperature or higher temperature, and has certain limitations in stability and portable design[15,16]. An aptamer is a short DNA or RNA sequence that binds to a target with high affinity and strong specificity. Its function is similar to that of an antibody, but compared with an antibody,Aptamers have the advantages of small size, high stability, easy synthesis and low cost, which make it possible to replace antibodies as recognition elements, which has aroused the interest of researchers in developing aptamer-based cTnI sensing platforms[17,18]. In this paper, the new detection methods of cTnI are divided into two categories according to the signal transduction mode: optical and electrochemical, and the research progress of biosensors based on aptamer detection of cTnI is reviewed, the working principle and performance of different biosensors are summarized, and the future realization of home field detection is prospected.

2 Optical detection

Optical signal biosensor is based on the interaction between light field and biological recognition molecules for optical detection, which can be divided into two modes: unlabeled and labeled.In the label-free mode, the detection signal is directly generated by the interaction between the analytical material and the sensing platform, while in the labeled mode, the signal is generated by means of fluorescence and luminescence[19]. Optical detection method has been used in the field of cTnI detection because of its high sensitivity and wide detection range[20]. When cTnI is present in the detection platform, the binding of the aptamer to cTnI causes a change in the light signal in the reaction system, and the detection of the concentration of cTnI is converted into the measurement of the size of the light signal. A variety of aptamer-based optical detection methods have been developed, including fluorescence and electrochemiluminescence[21][22].

2.1 Fluorescence method

Fluorescence method is one of the common optical techniques, which is often used in the field of aptamer-based biochemical detection. Some analytes can not emit fluorescence by themselves, so fluorescent probes are usually constructed by modifying fluorescent agents at the end of aptamers or nucleic acid chains to provide fluorescent signals[23~25]. One of the detection principles is that the existence of the target makes the fluorescent agent end of the fluorescent probe far away from the quencher so as to realize the recovery of the fluorescent signal. For example, Li et al. Modified fluorescein at one end of the cTnI aptamer sequence, and designed a new fluorescent aptamer sensor based on graphene oxide to detect cTnI. The principle is shown in Figure 1[26]. Graphene oxide materials can not only adsorb aptamers, but also quench the fluorescence signal. When the cTnI aptamer with fluorescence signal is adsorbed on the surface of graphene oxide, the fluorescence signal is quenched. Because the aptamer has a stronger affinity with cTnI, in the presence of cTnI, the aptamer leaves the graphene oxide and binds to cTnL, and the fluorescence signal is restored. The detection limit of the method was 0. 07 ng/mL and the linear range was 0. 1 ~ 6.0 ng/mL, but the detection of cTnI in serum was greatly affected by the background signal. Large background signal will lead to inaccurate experimental results and misdiagnosis of acute myocardial infarction, so it is necessary to develop detection methods that are less affected by background signal. Wong et al. Used a fluorescent dye, SPM, which turns on the fluorescence of DNA, to provide a fluorescent signal[27]. They immobilized cTnI antibodies on silica micro-nanoparticles to capture cTnI, and the aptamer of the end-modified hybridization chain reaction triggered chain was bound to cTnL, which hybridized with the other two types of hairpin DNA to start the hybridization chain reaction. The linear DNA amplification unit generated by the reaction was labeled by SPM to produce a strong fluorescence signal, which realized the conversion of cTnI concentration signal to fluorescence signal. The method is less affected by the background signal in the detection of human serum samples, and the detection limit is 0. 20 pg/mL, which is far below the concentration range of cTnI in healthy human serum.
图1 基于GO平台的cTnI检测适体传感器示意图[26]

Fig.1 Schematic representation of aptamer sensor for cTnI detection based on GO platform[26]

The fluorescence signal can be provided by the fluorescent probe, and the fluorescent agent of the fluorescent probe is far away from the quencher in the presence of the target to achieve the recovery of the fluorescence signal. Based on this principle, L Lü et al. Combined the rolling circle amplification (RCA) with the aptamer, and developed an aptamer-based immuno-RCA combined with fluorescent probe method to detect cTnI[28]. The cTnI is captured by its antibody, and then binds to the cTnI aptamer that modifies the primer strand of the RCA reaction at the end, and starts RCA under the action of DNA polymerase. The long DNA strand generated by the reaction binds to the fluorescent probe, and the two ends of the fluorescent probe in the hairpin structure are separated so that the fluorescein is far away from the quencher, thus generating an amplified fluorescent signal. The method showed good specificity in the detection of real samples and was less affected by background signals. In addition, the experimental results showed that the detection limit of the method was as low as 7. 24 pg/mL. They developed another detection strategy, designed a new fluorescent probe based on the above detection principle, used graphene oxide as a quencher, modified fluorescein at one end of the probe and fixed it on graphene oxide to quench the fluorescence signal[29]. Because the fluorescent probe is more compatible with the DNA long chain generated by RCA, when cTnI exists in the reaction system, the fluorescent probe is separated from the graphene oxide and combined with the DNA long chain, the fluorescent signal is restored and amplified, and the detection of the concentration of cTnI is realized.
The aptamer-based fluorescence detection method for cTnI has the advantages of simplicity, high efficiency and low cost, and can provide a reference for clinical application.

2.2 SERS

The principle of surface-enhanced Raman spectroscopy (SERS) detection is to adsorb the target analyte on a properly rough metal surface. When the molecule is close to the rough metal surface, its vibrational spectrum intensity will be greatly enhanced, and then the Raman spectrometer is used to measure the Raman scattering[30]. At present, SERS has been widely used in the field of trace molecule detection because of its fast detection speed and high sensitivity[31]. Mazali et al. Designed a Fe3O4@SiO2@Ag nanoparticle synthesized by a magnetite core with a silicon shell in the middle and a flower-shaped silver layer, and immobilized the aptamer on the silver surface to form a detection system[32]. The magnetic aggregation provided by the Fe3O4 magnetic core and the binding of the Ag tip induced the generation of a large number of hot spots, which enhanced the SERS response of the substrate. This detection system has the advantages of high sensitivity and fast detection speed, but it is easily interfered by other molecules, so it still needs to optimize and improve the detection method before it can be used for the detection of actual samples. Li et al. Developed a tag-based SERS detection strategy[33]. The Raman signal molecule was selected as CBBG, which does not need to be modified on the protein molecule by chemical bonds, thus optimizing the complex and time-consuming modification process. In this detection strategy, cTnI aptamer was immobilized on magnetic nanoparticles to make a magnetic capture probe. When cTnI was added to the reaction system, the capture probe separated and enriched cTnL, and CBBG was added to combine with cTnL to provide an enhanced SERS signal. The results showed that the detection limit of this strategy was 5. 50 pg/mL, and the linear range was 0. 01 ~ 100 ng/mL, which could be used for the detection of cTnI in human serum. Kim et al. Proposed a method for detecting cTnI by immobilizing an aptamer on an atomically flat gold nanoplatform[34]. They developed an atomically flat gold nanoplate for immobilizing the cTnI primary aptamer. In the presence of the target, the secondary aptamer modified with gold nanoparticles and Raman dye is combined with the target to form a sandwich structure, which can provide a strong SERS signal at the nanogap between the nanoparticles and the nanoplate, and convert the cTnI concentration signal into a SERS signal. Experiments show that the detection limit of this strategy in serum is 2.4 pg/mL, which has potential diagnostic ability.
Surface-enhanced resonance Raman scattering (SERRS) occurs when the chromophore energy of the analyte is close to the excitation frequency used to excite plasmons and generate SERS. Tu et al. designed a method for aptamer-based cTnI detection on a paper fluid platform in combination with SERRS. The paper platform has five regions, and the detection principle is shown in Figure 2[35][36]. The aptamer functionalized SERRS active particles are stored in the binding pad in advance, the sample solution is introduced into the sample pad, after the running buffer is added, the cTnI and the SERRS active particles flow to the test line area together to be combined with the secondary aptamer on the test line area to form a sandwich structure, and the redundant SERRS active particle is combined with the DNA strand in the control line area. The increase of cTnI concentration will increase the number of SERRS active particles in the test line area, and the SERRS signal will increase accordingly. Measuring the SERRS signal in the test line area can quantify the cTnI concentration. SERRS can provide a signal 10 to 100 times that of SERS, which makes this method more sensitive, but the detection time of this method is longer and the detection range is narrower, so it is still necessary to find a better optimization scheme to solve the above problems.
图2 使用SERRS活性颗粒在纸平台上基于适体测定cTnI的原理图[36]

Fig.2 Schematic diagram of cTnI measurement based on aptamer using SERRS active particles on paper platform[36]

2.3 Electrochemiluminescence

Electrochemiluminescence (ECL) is a new technology combining electrochemistry and chemiluminescence, which is produced by high-energy electrons generated on the surface of the electrode during the emission of excited state photons formed in the transfer process.The biosensing principle is to detect the interaction between the biorecognition molecule and the analyte through the ECL emission change related to the ECL active substance. The detection method based on ECL has the advantages of simple equipment, short response time and low background signal, and is used for the quantitative detection of cTnI[37~39]. In recent years, semiconductor quantum dots, carbon materials and metal nanoclusters have been widely used in ECL system as luminescent materials[40]. Due to the aggregation-induced ECL phenomenon and the giant ECL characteristics of iridium-based complexes, cyclometalated iridium (III) -polyvinylpyridine polymer (CIPNP) showed higher intensity than classical ECL luminophore Ru(bpy)32+. Amini et al. Developed an ECL aptasensor to detect cTnI in combination with CIPNP, and the principle is shown in Fig. 3[41]. They used aptamer-modified gold nanoparticles, CIPNP and nitrogen-doped graphene modified electrodes to increase the load capacity and conductivity of the ECL aptamer sensor. The specific binding of cTnI with the aptamer led to the detachment of the aptamer from the electrode surface, thus enhancing the ECL signal. This principle was used to convert the response signal and realize the sensitive detection of cTnI. The method combines CIPNP and other materials to improve the ECL strength, the conductivity and load capacity of the sensor, and the sensitivity of the sensor is greatly improved. Jin et al. Then prepared a sandwich-type ECL sensor to detect cTnI using CdS quantum dots (QDs) as ECL emitter and AuNPs as plasma source[42]. CdS QDs were immobilized on the electrode, and carboxyl groups were generated and activated on the surface of QDs by reaction for binding to Tro4 aptamer, and mercaptoethanol (MCH) covered the nonspecific binding site. After adding the sample solution containing cTnI, the Tro4 aptamer, the Tro6 aptamer modified by AuNP and cTnI are combined to form a sandwich structure. The interaction between the luminophor and the gold nanoparticles leads to the resonance interaction between the excited ECL luminophors, realizes the surface plasmon enhanced electrochemiluminescence, and completes the ultrasensitive detection of cTnI. The results showed that the detection limit of this strategy was as low as 0. 75 fg/mL, and the linear detection range was 1 fg/mL ~ 10 ng/mL, which improved the sensitivity again compared with the previous method. However, the detection time of this method is as long as several hours, which is not conducive to clinical application, and the method needs to be optimized to shorten the detection time.
图3 检测cTnI的ECL传感器原理图[41]

Fig.3 Schematic diagram of ECL sensor for detecting cTnI[41]

Tu et al. Used luminol /H2O2 as a luminescent probe of ECL, and in-situ generated mesoporous silica membrane (MSF) with vertically aligned nanochannels on indium tin oxide (ITO) coated glass by reaction, and these nanochannels of MSF were used to pass the luminescent probe[43]. When the cTnI aptamer is modified at the edge of the nanochannel mouth, the combination of cTnI and the aptamer will cause the channel to be blocked and hinder the passage of the luminescent probe, thus causing the ECL signal to decrease and the EIS signal to increase. Using this principle, cTnI can be quantitatively analyzed by ECL and EIS in parallel, and the linear detection range is 0. 05 pg/mL ~ 10 ng/mL. The main advantage of the sensor is that it can quantify cTnI in parallel through ECL and EIS signal responses, which makes the detection results more reliable and accurate, but the response speed of the sensor is still at a slow level, and the detection time is up to 1. 5 H. In addition to the above methods, the researchers also designed a ratiometric sensing strategy for cTnI detection combined with electrochemiluminescence[44,45].
Methods based on optical detection of cTnI also include colorimetry and SPR[46][47]. Through the above studies, it can be seen that these methods have the advantages of high sensitivity, good specificity and good selectivity, which realize the sensitive detection of cTnI, and also provide a reference for the subsequent development of new optical detection methods.

3 Electrochemical detection

Electrochemical detection is an ideal method for the detection of biomarkers, which has been widely used in the field of cTnI detection in recent years because of its simple equipment, low cost and fast response[48]. The working principle of the electrochemical aptasensor is as follows: one is that the binding of the analyte and the aptamer causes the change of the electrode impedance or the interface redox capacitance, and the other is that the conformation of the aptamer after binding to the target changes the distance between the electrochemical redox probe and the electrode surface, resulting in the change of the redox current[49]. Square wave voltammetry (SWV), electrochemical impedance spectroscopy (EIS) and differential pulse voltammetry (DPV) are commonly used methods for signal conversion in electrochemical detection, which are applied to the quantitative analysis of cTnI[50~52].

3.1 Electrochemical impedance spectroscopy

EIS is often used to study interfacial electrochemical phenomena, and EIS detection using a target capture probe modified electrode is a reliable and stable method[53,54]. At present, researchers have developed many EIS-based electrochemical aptamer sensing platforms for the detection of cTnI, which have the advantages of easy operation and miniaturization[55]. The detection principle is that the capture of cTnI by the specific aptamer immobilized on the electrode surface will lead to the change of the impedance of the electrode surface, and the impedance will change with the change of cTnI concentration[56]. Modification of the electrode surface with materials with good electrochemical performance is helpful to improve the detection performance of the sensor. Zheng et al. Modified the MoS2 on the electrode and fixed the cTnI aptamer on it. When cTnI was added, due to the stronger binding between cTnL and aptamer, the aptamer was separated from the electrode surface and specifically bound to cTnL, resulting in impedance changes, which realized the detection of cTnI[57]. However, due to the instability of van der Waals force, MoS2 will have serious re-stacking, resulting in the reduction of active sites and poor conductivity when combined with other materials, which will affect the electrochemical performance. To overcome these shortcomings, a composite material CA-MoS2 composed of cellulose acetate (CA) and molybdenum disulfide (MoS2) was designed for the development of cTnI electrochemical aptasensor, which has a large number of exposed active sites and good electron transfer properties[58]. The sensitive detection of cTnI was achieved by modifying CA-MoS2 on the electrode and improving the electrochemical performance combined with the EIS method.
AuNPs have also been used in the development of electrochemical sensors due to their advantages such as large surface area and size controllability. Kitte et al. designed an electrochemical detection platform for cTnI based on EIS in combination with AuNPs, and the principle is shown in Figure 4[59]. Thiol groups were introduced on the surface of indium tin oxide (ITO) electrode after treatment, which was used to bind AuNPs. The cTnI aptamer modified by thiol at one end is bound to the AuNPs to capture cTnI, and the binding of the aptamer to the AuNPs leads to an increase in the impedance of the sensor in the presence of cTnL. EIS analysis showed that the detection limit was as low as 0. 055 pg/mL and had a wide linear range (between 0. 1 pg/mL and 10 ng/mL).The detection results of this strategy in human serum samples were satisfactory, and it is expected to be used for the detection of real samples in the future.
图4 EIS适体传感器检测过程[59]

Fig.4 EIS aptamer sensor detection process[59]

The above cTnI electrochemical aptasensor realizes the sensitive conversion of concentration signal to electrochemical signal through EIS. The introduction of materials with excellent electrochemical performance amplifies the electrochemical signal to improve the sensitivity. In addition, the sensor also shows excellent selectivity, achieving a low detection limit and a wide detection range.

3.2 Differential pulse voltammetry

DPV is also a commonly used biomarker quantitative analysis method in electrochemical detection. With the increase of target analyte, the peak current changes, thus realizing the conversion from analyte concentration signal to current signal[60]. Because the single-stranded DNA aptamer is prone to nonspecific adsorption and aggregation on the electrode surface, the binding of cTnI to the aptamer is hindered, and the sensitivity of the detection is affected. The DNA nano-tetrahedron (NTH) can inhibit the entanglement of aptamers and firmly adhere to the electrode surface due to its unique structure. Sun et al. Designed an electrochemical dual-aptamer biosensor in combination with NTH, and the principle is shown in Figure 5[61]. Firstly, the two aptamers were modified on the surface of bimetallic Cu @ Au nanoparticles modified magnetic metal-organic framework Fe3O4@UiO-66(Fe3O4@UiO-66/Cu@Au) to obtain non-enzymatic nanoprobe 1 (NP1), and the cDNA complementary to the two aptamers was modified on the Cu @ Au nanoparticles to form non-enzymatic nanoprobe 2 (NP2). The aptamer modify at one end of that NTH captures the cTnI, the aptamer on the NP1 is combine with the cTnI, and the NP2 is combined with the NP1 through base complementary pairing to form the cluster-based nanoprobe, which is used for catalytic reaction to amplify electrochemical signals and improve sensitivity. Finally, the quantitative detection of cTnI was realized by DPV. The higher the concentration of cTnI, the higher the peak current of DPV. The results showed that the detection limit was 16 pg/mL. The sensitivity was improved by optimizing the design of the nanocatalytic probe and modifying the NTH modified aptamer, and the detection limit was as low as 7. 5 pg/mL[62].
图5 结合NTH的电化学双适体生物传感器检测原理[61]

Fig.5 Detection principle of electrochemical dual aptamer biosensor combined with NTH[61]

Generally speaking, only aptamer binding to cTnI is not enough to produce enough signal intensity for quantitative analysis, so nanomaterials with signal amplification have been developed to improve the performance of electrochemical aptasensor.Jin et al. Assembled Au nanoparticles on the surface of indium oxide (In2O3) and developed a cubic Au/In2O3 nanomaterial, which significantly improved the conductivity[63]. The material is modified on the electrode and used for the immobilization of the aptamer, and when the cTnI is combined with the aptamer, the cTnI is negatively charged and hinders the electron transfer on the surface of the electrode, so that the DPV peak current is reduced, and the signal conversion is realized. This method simplifies the experimental operation and shortens the detection cycle, and the detection of cTnI can be completed in only 10 min. The detection limit is 0. 06 ng/mL and the linear detection range is 0. 1 ~ 1 000 ng/mL. In addition, Guo et al. Designed a composite nanomaterial of copper nanowires (CuNWs), redox graphene (rGO) and MoS2, and Yuan et al. Designed a composite nanomaterial of silver nanoparticles (AgNPs)/MoS2/rGO, both of which were used for the development of cTnI electrochemical aptasensor[64][65]. Wang et al. Proposed a new strategy to modify ferrocene covalent organic framework nanosheets (Fc-COFNs) on a gold electrode, and the cTnI aptamer attached to the Fc-COFNs played a shielding role, resulting in a significant reduction in the electrochemical signal[66]. After the solution to be detected is added, the aptamer is separated from the surface of the Fc-COFNs due to the stronger binding between the cTnI and the aptamer, the electrochemical signal is restored, the DPV peak current is increased, and the quantitative detection of the cTnI is realized. The results showed that the method had excellent performance, the detection limit was 2. 6 fg/mL, and the sensitivity was very high. However, if it is applied to the detection of real samples, the detection time still needs to be shortened, and the experimental operation can be optimized and the experimental steps can be simplified to achieve rapid detection.

3.3 Square wave voltammetry

SWV is a general voltammetry technique often used in areas such as analytical applications[67]. In analytical applications, SWV demonstrates shorter analysis times and the ability to significantly reduce capacitive currents compared to other voltammetric methods[68]. An electrochemical aptamer sensing platform based on SWV and nanomaterials has shown excellent performance in cTnI quantitative analysis. Ban et al. Designed an electrochemical sensing platform based on SWV using ferrocene-modified silica nanoparticles (Fc-SiNPs)[69]. Fc-SiNPs as an electrochemically active probe for electron transfer. In the absence of cTnI, the aptamer self-assembled monolayer allowed Fc-SiNPs to enter the electrode surface to generate a large current signal, while in the presence of cTnI, the specific binding of aptamer and cTnI prevented Fc-SiNPs from entering the electrode surface and reduced the current signal. Based on this principle, SWV was used for quantitative determination, and the oxidation peak current decreased in different degrees according to the concentration of cTnI. The results showed that the detection limit of the platform in buffer was 24 pg/mL. A terminal deoxynucleotidyl transferase (TdT) -mediated signal amplification strategy was used to design the electrochemical sensor, and the principle is shown in Fig. 6[70]. Probe 2 (P2) was modified on the gold electrode, and the cTnI aptamer chain was bound to probe 1 (P1). When cTnI was added, the aptamer was dissociated from P1 and bound to cTn1, and the free P1 was bound to P2 to form a DNA hybrid double strand. In the presence of TdT and dTTP, TdT mediates the extension of P1 to form an ultra-long polythymine nucleic acid strand (polyT), which is used to bind a large amount of polyadenine strand (polyA) modified methylene blue (MB) to the electrode surface. Because MB is an electron transfer mediator, the electrochemical signal is amplified and the sensitivity of cTnI detection is improved. SWV was used for quantitative analysis, and cTnI was successfully detected in human serum, urine and saliva.
图6 cTnI检测原理图[70]

Fig.6 cTnI detection schematic diagram[70]

Salama et al. Employed laser etched graphene (LSG) electrode with easy surface modification and fabrication and modified with novel ferrite zinc nanoparticles (ZnFe2O4NPs), which significantly improved the sensitivity and electrocatalytic activity[71]. The thiol-modified DNA aptamer was immobilized on the electrode surface, and the aptamer combined with cTnI to block the diffusion of the redox probe to the electrode surface, resulting in a decrease in the peak current. The SWV was used to measure the peak current before and after the addition of cTnI to complete the quantification of cTcI. Experimental analysis shows that this strategy is promising for integration into point-of-care (POC) devices for the detection of cTnI.
In addition to the above methods, researchers have developed other electrochemical detection platforms. For example, Ban et al. Developed a sandwich biosensor using amperometry[72]. The electrode surface was modified by electrodeposition of gold nanoparticles and electropolymerization of conductive polymer, and the aptamer Tro4 was immobilized on the electrode surface, and hydrazine was modified at one end of the aptamer Tro6 as a detection probe. In the presence of cTnI, the three were combined to form a sandwich structure. This strategy enables the quantification of cTnI by detecting the amperometric signal generated by the catalytic reaction between hydrazine and H2O2. Villalonga et al. Constructed a sandwich-type amperometric aptamer sensor by combining the amino-modified aptamer (Apt-NH2) and aptamer-peroxidase conjugate (Apt-HRP) with the nanomaterial carboxyethylsilanetriol modified graphene oxide (CES-GO) as the transducing element modified electrode[73]. In the presence of cTnI, Apt-HRP and Apt-NH2 formed a sandwich structure, and HRP increased with the increase of cTnI. Under the catalysis of HRP, the current signal is amplified, the concentration signal is converted into a current signal, and finally the signal is measured by amperometry. After that, Lan et al. Designed an Au modified zirconium-based conductive carbon (Au/Zr-C) modified electrode, which reduced the background signal, improved the electrochemical performance and increased the sensitivity[74]. In addition, they designed a snowflake-like PtCuNi ternary metal alloy as a catalyst, which further improved the sensitivity, with a detection limit of 1.24 fg/mL, showing excellent performance in the quantitative analysis of cTnI. Interdigitated electrodes were also used to construct an electrochemical sensing platform for cTnI. Gopinath et al. Immobilized gold nanoparticles (GNPs) modified aptamers on the interdigitated electrodes to capture cTnI, and realized the conversion of response signals through electroanalysis, which improved the sensitivity compared with pure aptamers as capture probes[75]. Electrochemical detection has the advantages of low cost, simple equipment and fast response, and has great potential in the research and development of miniaturized and portable equipment[76]. However, electrochemical aptamer biosensors usually need to modify the aptamer on the electrode surface to form a sensitive functional coating, which is easy to fall off under biological fluids, dry air, voltage pulses and other factors, which limits the wide application of electrochemical aptamer biosensors[77]. Aptamer sensors based on optical signals are not affected by the operation of aptamer fixation and modification. Compared with electrochemical signal sensors, they have better stability and higher sensitivity. At present, some optical biosensors have entered the market, but most of them are more expensive.This is because the sensitivity of optical signal biosensors depends on more complex molecular systems. It will be one of the research directions of optical signal biosensors to reduce the dependence on complex molecular reaction systems by developing optical biosensors based on new principles and methods[78]. Therefore, there is still much room for the development of aptamer sensors based on electrochemical and optical signals for home diagnosis of AMI.

4 Conclusion and prospect

A sensitive, rapid and portable cTnI assay is of great significance for the early and rapid diagnosis of AMI. Aptamers have the characteristics of easy synthesis, low cost and good thermal stability, and have good application prospects in the field of biochemical sensing. Aptamer-based cTnI detection platforms have shown similar sensitivity to immunoassays, and the performance of cTnI detection platforms has been gradually improved with the development of new nanomaterials and signal amplification technologies. However, aptamer-based cTnI sensors have not yet been applied in clinical diagnosis, and there are still some problems and challenges to be solved.
To sum up, in order to meet the urgent needs of clinical application of aptamer-based cTnI sensors, first of all, researchers need to continuously improve the response speed of aptamers and solve the problem of slow combination of aptamers with cTnI. Yang Chaoyong of Xiamen University proposed to use machine learning methods to improve the accuracy and efficiency of aptamer recognition[79]. Secondly, new sensitive materials based on aptamers are developed to promote the sensitization and portability of aptamer biosensors, for example, aptamer DNA molecules are used as non-covalent crosslinking units to construct intelligent DNA hydrogels, and biosensitive materials with good stability and biocompatibility, adjustable pore size and function are studied[80,81]. Finally, the body-fitted sensor based on new principles and new methods is developed to gradually improve the user-friendliness of the cTnI detection device. The research of the focusing distance signal sensor in our research group can present the detection signal in the form of a thermometer, which greatly reduces the difficulty of user operation while improving the portability of the detection device[82]. In conclusion, screening aptamer molecules with faster response speed, developing more portable and easy-to-operate cTnI sensing technology, and promoting the commercialization process of aptamer sensors will be one of the effective ways to achieve home detection of cTnI in AMI patients and reduce the mortality of cardiovascular diseases.
[1]
Wang Y Q, Liu T, Yang M, Wu C J, Zhang W, Chu Z Y, Jin W Q. Biosens. Bioelectron., 2021, 193: 113554.

[2]
Khushaim W, Peramaiah K, Beduk T, Teja Vijjapu M, Ilton de Oliveira Filho J, Huang K W, Mani V, Salama K N. Biosens. Bioelectron. X, 2022, 12: 100234.

[3]
Campu A, Muresan I, Craciun A M, Cainap S, Astilean S, Focsan M. Int. J. Mol. Sci., 2022, 23(14): 7728.

[4]
Park K C, Gaze D C, Collinson P O, Marber M S. Cardiovasc. Res., 2017, 113(14): 1708.

[5]
Komarova N, Panova O, Titov A, Kuznetsov A. Biomedicines, 2022, 10(5): 1085.

[6]
Yang H Z, Chu Y R, Wang Q X, Ding C F, Gao F. Anal. Chem., 2021, 49 (5): 779.

(杨海珠, 褚亚茹, 汪庆祥, 丁彩凤, 高凤. 分析化学, 2021, 49 (5): 779.).

[7]
Yuan Z P, Wang L, Chen J, Su W G, Li A Q, Su G S, Liu P B, Zhou X X. Anal., 2021, 146(18): 5474.

[8]
Bernadou A, Bouges S, Catroux M, Rigaux J C, Laland C, Levêque N, Noury U, Larrieu S, Acef S, Habold D, Cazenave-Roblot F, Filleul L. BMC Infect. Dis., 2021, 21(1): 198.

[9]
Di Lallo A, Murphy R, Krieger A, Zhu J X, Taylor R H, Su H. IEEE Robotics Autom. Mag., 2021, 28(1): 18.

[10]
Lee T, Ahn J H, Choi J, Lee Y, Kim J M, Park C, Jang H, Kim T H, Lee M H. Micromachines, 2019, 10(3): 203.

[11]
Miao L Y, Jiao L, Tang Q R, Li H, Zhang L H, Wei Q. Sens. Actuat. B Chem., 2019, 288: 60.

[12]
Çimen D, Bereli N, Günaydın S, Denizli A. Talanta, 2020, 219: 121259.

[13]
Cen S Y, Ge X Y, Chen Y, Wang A J, Feng J J. Microchem. J., 2021, 169: 106568.

[14]
Gopinathan P, Sinha A, Chung Y D, Shiesh S C, Lee G B. Anal., 2019, 144(16): 4943.

[15]
Toh S Y, Citartan M, Gopinath S C B, Tang T H. Biosens. Bioelectron., 2015, 64: 392.

[16]
Zhao H, Cao L L, Liu Q, Tang F, Chen L, Wang S J, Li Y Y, Li Y, Li B, Liu H. Sens. Actuat. B Chem., 2022, 351: 130970.

[17]
Lopa N S, Rahman M M, Ahmed F, Ryu T, Sutradhar S C, Lei J, Kim J, Kim D H, Lee Y H, Kim W. Biosens. Bioelectron., 2019, 126: 381.

[18]
Cen Y, Wang Z P, Ke P X, Zhu W T, Yuan Z W, Feng S L, Chen Y Q, Lin C Y, Liu X M, Li Y T, Yan P K. Anal. Bioanal. Chem., 2021, 413(28): 7043.

[19]
Damborský P, Švitel J, Katrlík J. Essays Biochem., 2016, 60(1): 91.

[20]
Han X, Li S H, Peng Z L, Othman A M, Leblanc R. ACS Sens., 2016, 1(2): 106.

[21]
Rezaei Z, Ranjbar B. Eng. Life Sci., 2017, 17(2): 165.

[22]
Liu X, Liu H W, Li M, Qi H L, Gao Q, Zhang C X. ChemElectroChem, 2017, 4(7): 1708.

[23]
Feng C J, Dai S, Wang L. Biosens. Bioelectron., 2014, 59: 64.

[24]
Zheng P, Wu N Q. Chem. Asian J., 2017, 12(18): 2343.

[25]
Kazemi Asl S, Rahimzadegan M. Crit. Rev. Anal. Chem., 2023, 53(3): 594.

[26]
Liu D K, Lu X, Yang Y W, Zhai Y Y, Zhang J, Li L. Anal. Bioanal. Chem., 2018, 410(18): 4285.

[27]
Wong K W, Xu D, He D G, Wong M S, Li H W. Sens. Actuat. B Chem., 2019, 291: 200.

[28]
Li Y, Yang Y Z, X F, Deng Y L. J. Beijing Inst. Technol., 2020, 29(1): 45.

[29]
Li Y, Dai W Q, Lv X F, Deng Y L. Anal. Methods, 2018, 10(15): 1767.

[30]
Smith W E. Chem. Soc. Rev., 2008, 37(5): 955.

[31]
Fu J T, Lai H S, Zhang Z M, Li G K. Anal. Chimica Acta, 2021, 1161: 338464.

[32]
Alves R S, Sigoli F A, Mazali I O. Nanotechnology, 2020, 31(50): 505505.

[33]
Lin C B, Li L J, Feng J, Zhang Y, Lin X, Guo H, Li R. Microchimica Acta, 2022, 189(1): 1.

[34]
Lee H, Youn H, Hwang A, Lee H, Park J Y, Kim W, Yoo Y, Ban C, Kang T, Kim B. Nanomaterials, 2020, 10(7): 1402.

[35]
McNay G, Eustace D, Smith W E, Faulds K, Graham D. Appl. Spectrosc., 2011, 65(8): 825.

[36]
Tu D D, Holderby A, CotÉ G L. J. Biomed. Opt., 2020, 25(9): 097001.

[37]
Chen Y, Zhou S W, Li L L, Zhu J J. Nano Today, 2017, 12: 98.

[38]
Fereja T H, Du F X, Wang C, Snizhko D, Guan Y R, Xu G B. J. Anal. Test., 2020, 4(2): 76.

[39]
Shi Z X, Li G K, Hu Y F. Chin. Chem. Lett., 2019, 30(9): 1600.

[40]
Zhu L P, Ye J, Yan M X, Zhu Q J, Wang S, Huang J S, Yang X R. ACS Sens., 2019, 4(10): 2778.

[41]
Saremi M, Amini A, Heydari H. Microchimica Acta, 2019, 186(4): 1.

[42]
Kitte S A, Tafese T, Xu C, Saqib M, Li H J, Jin Y D. Talanta, 2021, 221: 121674.

[43]
Mi X N, Li H, Tan R, Tu Y F. Anal. Chem., 2020, 92(21): 14640.

[44]
Han Z L, Shu J N, Liang X, Cui H. Anal. Chem., 2019, 91(19): 12260.

[45]
Mi X N, Li H, Tan R, Feng B N, Tu Y F. Biosens. Bioelectron., 2021, 192: 113482.

[46]
Dorraj G S, Rassaee M J, Latifi A M, Pishgoo B, Tavallaei M. J. Biotechnol., 2015, 208: 80.

[47]
Lee T, Kim J, Nam I, Lee Y, Kim H E, Sohn H, Kim S E, Yoon J, Seo S W, Lee M H, Park C. Nanomaterials, 2019, 9(7): 1000.

[48]
Sheng Q L, Qiao X J, Zhou M, Zheng J B. Microchimica Acta, 2017, 184(6): 1573.

[49]
Li Z H, Mohamed M A, Vinu Mohan A M, Zhu Z G, Sharma V, Mishra G K, Mishra R K. Sensors, 2019, 19(24): 5435.

[50]
Luo Z B, Sun D P, Tong Y L, Zhong Y S, Chen Z G. Microchimica Acta, 2019, 186(6): 1.

[51]
Kumar S, Kalkal A. Nanotechnology in Cancer Management. Amsterdam: Elsevier, 2021, 43.

[52]
Kaya H O, Cetin A E, Azimzadeh M, Topkaya S N. J. Electroanal. Chem., 2021, 882: 114989.

[53]
Siddiqui S, Dai Z T, Stavis C J, Zeng H J, Moldovan N, Hamers R J, Carlisle J A, Arumugam P U. Biosens. Bioelectron., 2012, 35(1): 284.

[54]
Daniels J, Pourmand N. Electroanalysis, 2007, 19(12): 1239.

[55]
Magar H S, Hassan R Y A, Mulchandani A. Sensors, 2021, 21(19): 6578.

[56]
Gobalu K, Vasudevan M, Gopinath S C B, Perumal V, Ovinis M. Cellulose, 2021, 28(9): 5761.

[57]
Qiao X J, Li K X, Xu J Q, Cheng N, Sheng Q L, Cao W, Yue T L, Zheng J B. Biosens. Bioelectron., 2018, 113: 142.

[58]
Vasudevan M, Tai M J Y, Perumal V, Gopinath S C B, Murthe S S, Ovinis M, Mohamed N M, Joshi N. J. Taiwan Inst. Chem. Eng., 2021, 118: 245.

[59]
Kitte S A, Bushira F A, Soreta T R. J. Iran. Chem. Soc., 2022, 19(2): 505.

[60]
Yola M L, Atar N. Biosens. Bioelectron., 2019, 126: 418.

[61]
Sun D P, Luo Z B, Lu J, Zhang S S, Che T, Chen Z G, Zhang L Y. Biosens. Bioelectron., 2019, 134: 49.

[62]
Sun D P, Lin X G, Lu J, Wei P, Luo Z B, Lu X G, Chen Z G, Zhang L Y. Biosens. Bioelectron., 2019, 142: 111578.

[63]
Xu W J, Liu T, Wang Y Q, Zhang W, Yao X Y, Hou B L, Xie Y, Chu Z Y, Jin W Q. Electroanalysis, 2021, 33(7): 1810.

[64]
Han Y J, Su X J, Fan L F, Liu Z G, Guo Y J. Microchem. J., 2021, 169: 106598.

[65]
Li J, Zhang S W, Zhang L, Zhang Y, Zhang H, Zhang C X, Xuan X X, Wang M J, Zhang J Y, Yuan Y Q. Front. Chem., 2021, 9: 680593.

[66]
Song Z P, Song J, Gao F, Chen X P, Wang Q H, Zhao Y N, Huang X G, Yang C Y, Wang Q X. Sens. Actuat. B Chem., 2022, 368: 132205.

[67]
Mirčeski V, Stojanov L, Skrzypek S. Contributions Sect. Nat. Math. Biotech. Sci., 2018, 39(2): 103.

[68]
Mirceski V, Gulaboski R, Lovric M, Bogeski I, Kappl R, Hoth M. Electroanalysis, 2013, 25(11): 2411.

[69]
Jo H, Gu H, Jeon W, Youn H, Her J, Kim S K, Lee J, Shin J H, Ban C. Anal. Chem., 2015, 87(19): 9869.

[70]
Lang M J, Luo D, Yang G Y, Mei Q X, Feng G J, Yang Y, Liu Z H, Chen Q H, Wu L. RSC Adv., 2020, 10(60): 36396.

[71]
Rauf S, Mani V, Lahcen A A, Yuvaraja S, Beduk T, Salama K N. Electrochimica Acta, 2021, 386: 138489.

[72]
Jo H, Her J, Lee H, Shim Y B, Ban C. Talanta, 2017, 165: 442.

[73]
Villalonga A, Estabiel I, PÉrez-Calabuig A M, Mayol B, Parrado C, Villalonga R. Biosens. Bioelectron., 2021, 183: 113203.

[74]
Chen K C, Zhao H L, Wang Z X, Zhou F F, Shi Z H, Cao S D, Lan M B. Biosens. Bioelectron., 2022, 212: 114431.

[75]
Zhang J T, Lakshmipriya T, Gopinath S C B. ACS Omega, 2020, 5(40): 25899.

[76]
Bezinge L, Suea-Ngam A, deMello A J, Shih C J. Mol. Syst. Des. Eng., 2020, 5(1): 49.

[77]
Shaver A, Arroyo-Currás N. Curr. Opin. Electrochem., 2022, 32: 100902.

[78]
Chen C, Wang J S. Anal., 2020, 145(5): 1605.

[79]
Song J, Zheng Y, Huang M J, Wu L L, Wang W, Zhu Z, Song Y L, Yang C Y. Anal. Chem., 2020, 92(4): 3307.

[80]
Li F Y, Lyu D Y, Liu S, Guo W W. Adv. Mater., 2020, 32(3): 1806538.

[81]
Khajouei S, Ravan H, Ebrahimi A. Adv. Colloid Interface Sci., 2020, 275: 102060.

[82]
Li Y S, Ma Y L, Jiao X Y, Li T Y, Lv Z H, Yang C J, Zhang X J, Wen Y Q. Nat. Commun., 2019, 10(1): 1036.

Outlines

/